Harvest Portfolios Group Reduces Stake in AbbVie

Investment firm lowers position in pharmaceutical giant by 3.8% in Q3

Mar. 3, 2026 at 8:15am

Got story updates? Submit your updates here. ›

Harvest Portfolios Group Inc. lowered its stake in shares of AbbVie Inc. (NYSE:ABBV) by 3.8% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 285,569 shares of the company's stock after selling 11,259 shares during the period. AbbVie makes up 1.2% of Harvest Portfolios Group Inc.'s investment portfolio, making the stock its 17th biggest holding.

Why it matters

This filing provides insight into the investment strategy and portfolio adjustments of Harvest Portfolios Group, a notable institutional investor. Changes in large shareholders' positions can signal shifts in market sentiment or portfolio rebalancing, which can impact a stock's performance.

The details

Harvest Portfolios Group Inc. sold 11,259 shares of AbbVie stock in the third quarter, reducing its total position to 285,569 shares. The investment firm's holdings in AbbVie were valued at $66,121,000 as of the most recent SEC filing.

  • Harvest Portfolios Group Inc. lowered its stake in the third quarter.

The players

Harvest Portfolios Group Inc.

An investment management firm that owns a 1.2% stake in AbbVie, making it the 17th largest holding in the firm's portfolio.

AbbVie Inc.

A global biopharmaceutical company that focuses on discovering, developing and commercializing therapies for complex and chronic medical conditions.

Got photos? Submit your photos here. ›

The takeaway

This filing highlights the ongoing portfolio adjustments of institutional investors like Harvest Portfolios Group as they manage their exposure to pharmaceutical giants like AbbVie. Such changes in large shareholder positions can provide valuable insights into market trends and sentiment.